Litcius/Paper detail

POLE/POLD1 mutation and tumor immunotherapy

Xiaoting Ma, Dong Lin, Xiu Liu, Kai Ou, Lin Yang

2022Journal of Experimental & Clinical Cancer Research129 citationsDOIOpen Access PDF

Abstract

POLE and POLD1 encode the catalytic and proofreading subunits of DNA polymerase ε and polymerase δ, and play important roles in DNA replication and proofreading. POLE/POLD1 exonuclease domain mutations lead to loss of proofreading function, which causes the accumulation of mutant genes in cells. POLE/POLD1 mutations are not only closely related to tumor formation, but are also a potential molecular marker for predicting the efficacy of immunotherapy in pan-carcinomatous species. The association of POLE/POLD1 mutation, ultra-high mutation load, and good prognosis have recently become the focus of clinical research. This article reviews the function of POLE/POLD1, its relationship with deficient mismatch repair/high microsatellite instability, and the role of POLE/POLD1 mutation in the occurrence and development of various tumors.

Topics & Concepts

ProofreadingBiologyDNA polymeraseMutationDNA replicationGeneticsPolymeraseMicrosatellite instabilityMutation AccumulationCancer researchMutation rateGeneMicrosatelliteAlleleGenetic factors in colorectal cancerCancer Genomics and DiagnosticsDNA Repair Mechanisms
POLE/POLD1 mutation and tumor immunotherapy | Litcius